Wireva
Get access
English Standard story link_only 02.11.2026 14:45 UTC v1 Science Official

Personalized mRNA Vaccine With Immunotherapy Shows Promise Against Melanoma Relapse

A trial involving 1,137 patients showed that a personalized mRNA vaccine combined with immunotherapy helps patients with high-risk melanoma, while experts stress that treatment should also be assessed by patients' quality of life.

5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial
PET-guided treatment de-escalation keeps HER2-positive breast cancer outcomes strong at five years
Jenny Mealing · CC BY 2.0 · rights

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.

Monitoring item. The full text is not distributed. Extract and source below.

A trial involving 1,137 patients showed that a personalized mRNA vaccine combined with immunotherapy helps patients with high-risk melanoma, while experts stress that treatment should also be assessed by patients' quality of life.